EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Renal outcomes and predictive value of dyslipidemia in patients with IgA nephropathy: a retrospective cohort study

Yiping Ruan, Qiaoyun Huang, Fuyuan Hong, Miao Lin, Chen Wang, Fayang Lian, Fang Cao, Guokai Yang, Lanting Huang, Xuejing Chen

Frontiers in Medicine · 15.04.2026 · 13

DOI: 10.3389/fmed.2026.1695909 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Medicine, online erschienen am 15.04.2026. Verfasst von Yiping Ruan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Shengli Clinical Medical College of Fujian Me…. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dyslipidemia is common in chronic kidney disease (CKD), including immunoglobulin A (IgA) nephropathy (IgAN), and may be associated with renal prognosis; however, the value of dyslipidemia in IgAN remains insufficiently assessed. The objective of our study was to investigate clinicopathological characteristics and renal outcomes in IgAN patients with dyslipidemia and to evaluate the prognostic value of lipid abnormalities.

Methods

This cohort study included 458 primary IgAN patients for a retrospective analysis. The clinicopathological features and renal outcomes were recorded. In univariate and multivariate models, the associations between dyslipidemia and renal outcomes, as well as dyslipidemia-associated pathological features, were analyzed.

Results

Patients with dyslipidemia—defined as a total cholesterol of ≥5.2 mmol/L, triglycerides of ≥1.7 mmol/L, or low-density lipoprotein cholesterol [LDL-C] of ≥3.4 mmol/L—exhibited elevated complement levels and worse clinical characteristics with regard to blood pressure, proteinuria, kidney function, and glomerulosclerosis; tubular atrophy/interstitial fibrosis (T1–2), crescents, and vascular lesions were more common. A multivariate logistic regression revealed that T1–2 and arterial intimal fibrosis were significantly associated with dyslipidemia. After a mean follow-up of 54.7 months, dyslipidemia ( p = 0.001), especially abnormalities in total cholesterol ( p = 0.016) and triglycerides ( p = 0.001), was significantly associated with poorer renal survival, and renal survival was not improved after lipid-lowering therapies. In addition to estimated glomerular filtration rate (eGFR) and arterial intimal fibrosis, dyslipidemia is an independent predictor for renal survival in multivariate Cox analyses (model 1: HR, 2.206; 95% CI, 1.127–4.317; p = 0.021; model 2: HR, 2.085; 95% CI, 1.059–4.106; p = 0.034).

Conclusion

IgAN patients with dyslipidemia exhibited more severe clinicopathological features. Tubular atrophy/interstitial fibrosis and arteriosclerosis/arteriolosclerosis were closely associated with dyslipidemia. Dyslipidemia not only indicates adverse renal outcomes but also serves as an independent prognostic predictor.

Schlagwörter

Stichwörter der Autor:innen

IgA nephropathycharacteristicsdyslipidemiaoutcomeprediction

Autor:innen und Institutionen

  • Department of Nephrology, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Computer Engineering, Fuzhou University Zhicheng College, Fuzhou, Fujian, China.
  • Department of Pathology, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
  • Epidemiology and Clinical Research Unit, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.

Zitieren

APA

Ruan, Y., Huang, Q., Hong, F., Lin, M., Wang, C., Lian, F., Cao, F., Yang, G., Huang, L., & Chen, X. (2026). Renal outcomes and predictive value of dyslipidemia in patients with IgA nephropathy: a retrospective cohort study. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1695909

Vancouver

Ruan Y, Huang Q, Hong F, Lin M, Wang C, Lian F, et al. Renal outcomes and predictive value of dyslipidemia in patients with IgA nephropathy: a retrospective cohort study. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1695909

BibTeX
@article{Ruan2026,
  author = {Ruan, Yiping and Huang, Qiaoyun and Hong, Fuyuan and Lin, Miao and Wang, Chen and Lian, Fayang and Cao, Fang and Yang, Guokai and Huang, Lanting and Chen, Xuejing},
  title = {Renal outcomes and predictive value of dyslipidemia in patients with IgA nephropathy: a retrospective cohort study},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1695909}
}
Kostenlos starten →